Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Insider Trading is Good News for These Stocks

INSIDER TRADING text written on a notebook with chart

The threat of fines and imprisonment, up to twenty years for the worst offenders, makes insider trading a different game than what it was. Today, insiders must reveal their trading within days of execution or face the fullest extent of the law. Savvy investors can use those filings to uncover hot trades and follow the leader to investment success; Insidertrades.com tracks those trades, so you don’t have to. This article highlights the top three stocks insiders bought over a 90-day look-back period; all are moving higher and have ample upside potential. 

A Major Shareholder Doubles-Down on Perspective Therapeutics

Perspective Therapeutics (NYSE: CATX) focuses on targeted alpha oncology therapies. It has several therapies in late-stage clinical trials, a partnership to develop therapies with Bristol-Meyers Squibb (NYSE: BMY), and a major shareholder recently doubled down on their holdings. Lantheus Holdings (NASDAQ: LNTH) is a major developer, manufacturer, and distributor of medical diagnostic and therapeutic products worldwide. It purchased roughly 60 million shares, nearly doubling its position bringing the stake to nearly 20%. This is a significant increase in ownership and validation of the business and pipeline. Perspective Therapeutics is the most bought by insiders by share count. 

Market support for Perspective Therapeutics is strong. Insidertrades.com tracks six analysts that peg the stock with a consensus Buy rating. The Buy rating has been steady for the last year, but the price target is increasing. The price target revisions lifted the consensus target by 50% in twelve months, with recent activity at the high end of the range. The freshest target is the highest on Wall Street; the Royal Bank of Canada set it and projects a price of $3.00 or nearly 100% upside. Coincidentally, the most-bought stock by dollar value is also a pharma company that was recently bought out.

CATX stock chart

Liberty Live Group has a Friend in Warren Buffett 

Liberty Live Group (NASDAQ: LLYVA) is a complex media company with assets including Formula One (NASDAQ: FWONK) and SiriusXM Radio (NASDAQ: LSXMA). The stock structure is more complex, with at least nine tracking stocks to cover the different business aspects with voting and non-voting rights.

Today’s takeaway is that Berkshire Hathaway (NYSE: BRK-A) owns seven. The positions are high double-digit stakes in most cases, and the firm has been adding to the bulk position this year. The target appears to be SiriusXM, but Liberty Live and Formula One are in the mix. 

Analysts are bullish on the group. However, shares of Sirius Series A and C (NASDAQ: LSXMK), the ones most bought by Berkshire, are the most undervalued. Insidertrades.com tracks four analysts with a Moderate Buy rating and a $37.65 price target. That target implies a 55% upside for the stock, putting it at a multi-year high and in full reversal. A move to that level would be bullish and open the door to another $12 of upside. 

NB Bancorp is an Aged Institution With Lots of Value

NB Bancorp (NASDAQ: NBBK) has been in business for over 130 years, offering financial services in Massachusetts and surrounding areas—the company only recently IPOd, seeking capital to finance targeted growth opportunities. The IPO was well-received and oversubscribed, leading to a meteoric rise in the share prices. Trading at $15.95, the stock is nearly 15% above its IPO price and still undervalued. The company’s tangible book is near $17.30, suggesting another 9% upside is the minimum to expect.

Insiders are buying this stock and not just one or two. Seven insiders, including several board members, the CEO, CFO, COO, and EVP, made eleven transactions in the look-back window, making this the most bought stock by activity. They own 1.7% of the stock, and institutional ownership is also rising. Institutions, including the bank’s employee benefit plan, own about 30% of the stock, and their buying accelerated from Q1 to Q2, providing a tailwind for the market. Only one analyst has a rating tracked by Insidertrades.com, but it’s a Buy with a price target above the current action. 

NBBK stock chart

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.